BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32721657)

  • 1. Electrocardiographic QRS voltage amplitude improvement by intramyocardial radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy and one year follow up.
    Zuo L; Hsi DH; Zhang L; Zhang Q; Shao H; Liu B; Lei C; Ye C; Meng X; Zhang G; Zhou M; Li J; He Y; Guo J; Liu L
    J Electrocardiol; 2020; 61():164-169. PubMed ID: 32721657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
    Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Liu L; Li J; Zuo L; Zhang J; Zhou M; Xu B; Hahn RT; Leon MB; Hsi DH; Ge J; Zhou X; Zhang J; Ge S; Xiong L
    J Am Coll Cardiol; 2018 Oct; 72(16):1898-1909. PubMed ID: 30309466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography Guided Liwen Procedure
    Liu L; Zhou M; Zuo L; Li J; Chen W; Xu B; Hsi DH
    Echocardiography; 2018 Aug; 35(8):1230-1232. PubMed ID: 29870575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy.
    Wang Z; Zhao R; Sievert H; Ta S; Li J; Bertog S; Piayda K; Zhou M; Lei C; Li X; Liu J; Xu B; Feng B; Hu R; Liu L
    Front Cardiovasc Med; 2022; 9():1028763. PubMed ID: 36440055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
    Qian D; Zhou X; Liu H; Cao L
    J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.
    Li J; Zhang J; Shi Y; Sievert H; Taub CC; Bertog S; Ta S; Changhui L; Senser E; Wang J; Hu R; Huang J; Ruan F; Han Y; Li X; Wang B; Zhao X; Liu J; Hsi DH; Liu L
    Heart; 2023 Jan; 109(4):289-296. PubMed ID: 36270787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
    Yao L; Ta S; Wang J; Han C; Lei C; Li W; Li J; Wang B; Zhao X; Liu L
    Int J Cardiovasc Imaging; 2024 May; ():. PubMed ID: 38709352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
    Zhou M; Ta S; Hahn RT; Hsi DH; Leon MB; Hu R; Zhang J; Zuo L; Li J; Wang J; Wang B; Zhu X; Liu J; Han Y; Li X; Xu B; Zhang L; Hou L; Han C; Liu J; Liu L
    JAMA Cardiol; 2022 May; 7(5):529-538. PubMed ID: 35353129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Ta S; Li J; Hsi DH; Hu R; Lei C; Shan B; Li W; Wang J; Wang B; Kang N; Li X; Liu J; Qi C; Huang J; Han Y; Ruan F; Zhang J; Liu L
    Heart; 2024 May; 110(11):792-799. PubMed ID: 38388470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.
    He YG; Dong Y; Yang SH; Yang F; Yin JL; Zhao HQ; Zhao YJ
    Clin Cardiol; 2024 Feb; 47(3):e24217. PubMed ID: 38439605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Intramyocardial Septal Radiofrequency Ablation Relieving Residual Left Ventricular Outflow Tract Obstruction Following Alcohol Septal Ablation.
    Xu Y; Yu TY; Pu ZX
    CASE (Phila); 2022 Sep; 6(7):340-343. PubMed ID: 36172476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Interventricular Septal Reduction: An Ovine Model with 1-Year Outcomes.
    Liu F; Fu J; Hsi D; Sun C; He G; Hu R; Zhang J; Liu L
    Cardiology; 2020; 145(1):53-62. PubMed ID: 31747665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Yang H; Yang Y; Xue Y; Luo S
    Clin Cardiol; 2020 May; 43(5):450-458. PubMed ID: 32034788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial biopsy of Liwen procedure: representability and etiological diagnostic value of cardiac samples obtained by a novel technique in patients with hypertrophic cardiomyopathy].
    Han C; Zhou MY; Wu JF; Wang B; Ma H; Hu R; Zuo L; Li J; Li XJ; Ta SJ; Fan LN; Liu LW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):361-368. PubMed ID: 35399032
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-Septal Myocardial Biopsy in Hypertrophic Cardiomyopathy Using the Liwen Procedure: An Introduction of a Novel Technique.
    Han C; Zhou M; Hu R; Wang B; Zuo L; Li J; Ta S; Hsi DH; Liu J; Wei L; Liu L
    J Interv Cardiol; 2021; 2021():1905184. PubMed ID: 33628143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm.
    Zhang R; Zhao F; Wang J; Qin Y; Wang T; Chu AA
    Front Cardiovasc Med; 2023; 10():1278457. PubMed ID: 38028451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.